Metropolitan Life Insurance Company (MetLife)’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,110
| Closed | -$92.7K | – | 124 |
|
|
2024
Q1 | $92.7K | Sell |
2,110
-87
| -4% | -$4.49K | ﹤0.01% | 1088 |
|
|
2023
Q4 | $136K | Hold |
2,197
| – | – | 0.01% | 923 |
|
|
2023
Q3 | $101K | Buy |
2,197
+123
| +6% | +$6.71K | 0.01% | 1006 |
|
|
2023
Q2 | $119K | Hold |
2,074
| – | – | 0.01% | 929 |
|
|
2023
Q1 | $77.8K | Sell |
2,074
-193
| -9% | -$6.33K | ﹤0.01% | 1141 |
|
|
2022
Q4 | $63.5K | Hold |
2,267
| – | – | ﹤0.01% | 1329 |
|
|
2022
Q3 | $63.7K | Hold |
2,267
| – | – | ﹤0.01% | 1292 |
|
|
2022
Q2 | $78.9K | Hold |
2,267
| – | – | ﹤0.01% | 1207 |
|
|
2022
Q1 | $81.4K | Sell |
2,267
-7,848
| -78% | -$223K | ﹤0.01% | 1332 |
|
|
2021
Q4 | $236K | Sell |
10,115
-2,428
| -19% | -$49.6K | ﹤0.01% | 1917 |
|
|
2021
Q3 | $238K | Hold |
12,543
| – | – | ﹤0.01% | 1942 |
|
|
2021
Q2 | $253K | Buy |
12,543
+1,172
| +10% | +$22.1K | ﹤0.01% | 1980 |
|
|
2021
Q1 | $208K | Sell |
11,371
-830
| -7% | -$15.4K | ﹤0.01% | 1994 |
|
|
2020
Q4 | $245K | Hold |
12,201
| – | – | ﹤0.01% | 1802 |
|
|
2020
Q3 | $229K | Hold |
12,201
| – | – | ﹤0.01% | 1693 |
|
|
2020
Q2 | $274K | Hold |
12,201
| – | – | ﹤0.01% | 1605 |
|
|
2020
Q1 | $181K | Buy |
12,201
+387
| +3% | +$6.73K | ﹤0.01% | 1649 |
|
|
2019
Q4 | $228K | Sell |
11,814
-729
| -6% | -$14K | ﹤0.01% | 1823 |
|
|
2019
Q3 | $249K | Hold |
12,543
| – | – | ﹤0.01% | 1728 |
|
|
2019
Q2 | $265K | Hold |
12,543
| – | – | ﹤0.01% | 1707 |
|
|
2019
Q1 | $256K | Hold |
12,543
| – | – | ﹤0.01% | 1731 |
|
|
2018
Q4 | $250K | Hold |
12,543
| – | – | 0.01% | 1655 |
|
|
2018
Q3 | $241K | Hold |
12,543
| – | – | ﹤0.01% | 1881 |
|
|
2018
Q2 | $191K | Hold |
12,543
| – | – | ﹤0.01% | 1971 |
|
|
2018
Q1 | $235K | Buy |
12,543
+626
| +5% | +$11.8K | ﹤0.01% | 1793 |
|
|
2017
Q4 | $229K | Sell |
11,917
-14,388
| -55% | -$269K | ﹤0.01% | 1828 |
|
|
2017
Q3 | $470K | Hold |
26,305
| – | – | ﹤0.01% | 1730 |
|
|
2017
Q2 | $470K | Hold |
26,305
| – | – | ﹤0.01% | 1736 |
|
|
2017
Q1 | $381K | Hold |
26,305
| – | – | ﹤0.01% | 1846 |
|
|
2016
Q4 | $485K | Hold |
26,305
| – | – | ﹤0.01% | 1755 |
|
|
2016
Q3 | $499K | Hold |
26,305
| – | – | ﹤0.01% | 1710 |
|
|
2016
Q2 | $424K | Buy |
26,305
+2,637
| +11% | +$37.2K | ﹤0.01% | 1808 |
|
|
2016
Q1 | $284K | Hold |
23,668
| – | – | ﹤0.01% | 1935 |
|
|
2015
Q4 | $337K | Buy |
23,668
+1,191
| +5% | +$15.7K | ﹤0.01% | 1886 |
|
|
2015
Q3 | $263K | Sell |
22,477
-841
| -4% | -$12.6K | ﹤0.01% | 2084 |
|
|
2015
Q2 | $410K | Buy |
+23,318
| New | +$363K | ﹤0.01% | 1881 |
|
Other funds holding AMPH
EIP
Metropolitan Life Insurance Company (MetLife)'s AMPH Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 2,110 shares — an estimated $92.7K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AMPH in Q2 2015 and held it in 36 quarters. The position peaked at $499K in Q3 2016. 268 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,110 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $92.7K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Amphastar Pharmaceuticals in Q2 2015 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Amphastar Pharmaceuticals position peaked at $499K in Q3 2016.
- 268 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.